Weight Loss Drugs for Men vs Women: What the Research Shows

The same GLP-1 dose doesn’t produce the same result in everyone, and one of the clearest patterns is between men and women. On average, women lose a somewhat larger percentage of their body weight on these drugs than men do, though the medications work well for both. Women also tend to report more gastrointestinal side effects, while men may get slightly more cardiovascular benefit. None of this changes which drugs are used, but it can shape expectations. Here’s what the evidence says and how to think about it.

Women Tend to Lose a Bit More

The most direct evidence comes from a large research synthesis. In a systematic review and meta-analysis published in JAMA Internal Medicine in 2026, women lost about 11% of their body weight on GLP-1 drugs compared with about 7% for men. Notably, the drugs worked similarly across age, race, ethnicity, and starting BMI, so sex was the standout difference.

Why the gap exists isn’t fully settled. Researchers point to how these drugs interact with estrogen, along with differences in body composition and metabolism between men and women. Whatever the mechanism, the pattern shows up across multiple studies.

Side Effects and Other Differences

The picture isn’t one-sided. Women, who tend to lose more weight, also tend to report more nausea and other gastrointestinal side effects, which may relate to dosing relative to body size. Men, meanwhile, appear to derive somewhat greater cardiovascular benefit in some analyses. Both sexes respond well overall, and neither is steered toward a different medication because of sex.

Comparing the Picture

TrimRx prescribes compounded semaglutide and compounded tirzepatide along with the brand GLP-1s, and the medication choice is driven by your goals, health profile, and tolerance rather than by sex. What sex may influence is expectation-setting and side-effect management, both of which a provider can plan around.

Consider a hypothetical patient couple starting tirzepatide together. The woman might reasonably expect a somewhat larger percentage loss but may need a slower dose increase if nausea shows up, while her partner might see a slightly smaller percentage change with fewer stomach complaints. Same drug, slightly different experience, and both can succeed.

One practical point for women around menopause: some research suggests that women on estrogen-containing hormone therapy for menopausal symptoms lose more weight on GLP-1 drugs than those not on it. Hormone therapy isn’t used for weight loss itself, but if you’re already on it for symptoms, it may be part of the backdrop your provider considers.

Frequently Asked Questions

Do weight loss drugs work better for women than men?

On average women lose a slightly larger percentage of body weight, but the drugs work well for both. The difference is modest, and individual results vary more than the average gap between sexes.

Do men and women take different weight loss drugs?

No. The same options (semaglutide, tirzepatide, and the brands) are used for both. Sex may affect expected results and side-effect management, not the choice of medication.

Why do women report more side effects?

Women, who tend to lose more weight, also tend to report more nausea and GI effects, possibly related to dose relative to body size. A slower dose increase often helps manage this.

To see which option fits you, you can take the TrimRx quiz for a licensed provider’s review.

This article is for educational purposes and is not medical advice. Menopausal hormone therapy is used for symptoms, not weight loss. Consult a qualified healthcare provider about your care. Individual results vary.